Related Experiment Videos
Allelotype of renal cell carcinoma
R Morita1, J Ishikawa, M Tsutsumi
1Department of Biochemistry, SRL Incorporation, Kobe University, School of Medicine, Tokyo, Japan.
Cancer Research
|February 1, 1991
Summary
Genetic alterations drive cancer. This study investigated genetic changes in renal cell carcinoma, finding widespread loss of heterozygosity, suggesting multiple tumor suppressor genes are involved in kidney cancer development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Cancer development involves accumulating genetic alterations.
- Oncogene activation and tumor suppressor gene inactivation are key in tumor progression.
- Previous studies highlight these mechanisms in colorectal, lung, and breast cancers.
Purpose of the Study:
- To investigate genetic alterations during renal cell carcinoma (RCC) progression.
- To identify potential tumor suppressor genes involved in kidney cancer development.
Main Methods:
- Utilized restriction fragment length polymorphism (RFLP) markers across the genome.
- Analyzed loss of heterozygosity (LOH) in 38 renal cell carcinoma samples.
Main Results:
- Significant LOH observed on chromosome 3p in nearly 64% of tumors.
- Average LOH of approximately 30% noted at informative loci on chromosomes 5q, 6q, 10q, 11q, 17p, and 19p.
- These findings indicate widespread genetic instability in RCC.
Conclusions:
- Multiple genetic alterations, likely involving tumor suppressor genes, are implicated in renal cell carcinoma carcinogenesis.
- The study identifies specific chromosomal regions (3p, 5q, 6q, 10q, 11q, 17p, 19p) as critical in kidney cancer development.
- Further research into these tumor suppressor genes is warranted for understanding and treating RCC.